clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Marketplace
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Antibiotics
Original Penicillium Mold Genome Could Point to New Routes for Industrial…
Molecular Dx
New Cardiac Cell Atlas Could Fuel Personalized Heart Treatments
Coronavirus
Wide Variety in Accuracy of COVID-19 Antibody Tests Revealed
Coronavirus
Large Phase III Trial Launched for J&J’s COVID-19 Vaccine
Oncology
CRISPR Identifies Genes Allowing Cancer to Evade Immune Detection
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Antibiotics
Original Penicillium Mold Genome Could Point to New Routes for Industrial…
Molecular Dx
New Cardiac Cell Atlas Could Fuel Personalized Heart Treatments
Coronavirus
Wide Variety in Accuracy of COVID-19 Antibody Tests Revealed
Coronavirus
Large Phase III Trial Launched for J&J’s COVID-19 Vaccine
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Marketplace
Multimedia
All
Webinars
eBooks
Upcoming Webinars
Predicting Breast Cancer Outcomes Using AI Models and Federated Learning
Upcoming Webinars
Whole-Genome Sequencing Comes of Age in Clinical Care
Multimedia
Navigating Complexity in Oncology Cell and Gene Therapy Clinical Trials
Multimedia
Sequencing Controls Improve Confidence in NGS Patient Results
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Cancer Testing
Cancer Testing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cancer Testing
Illumina to acquire GRAIL for $8 Billion
September 21, 2020
Cancer Testing
Freenome Raises $270M in Series C Financing for Cancer Tests Based...
August 27, 2020
Cancer Testing
It’s in the Blood
August 4, 2020
Cancer Testing
Thrive Raises $257M in Series B to Advance CancerSEEK Liquid Biopsy
July 29, 2020
Cancer Testing
Canadian Consortium Backs Liquid Biopsy Solution to Increase Cancer Testing Access...
July 16, 2020
Cancer Testing
Foundation Medicine Eyes Liquid Biopsy Expansion, DNA Methylation Adoption, with Lexent...
June 12, 2020
Cancer Testing
NIH-Developed Blood Test Improves Liver Cancer Screening
June 12, 2020
Cancer Testing
Agilent and Visiopharm Plan to Merge Resources to Market Complimentary Cancer...
March 4, 2020
Cancer Testing
Cepheid, Sherlock to Develop Coronavirus Test, Part of Broader MDx Collaboration
March 2, 2020
Cancer Testing
Precision Oncology Company OncoDNA Closes $20M Series B Financing
February 14, 2020
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Epic Sciences said today its liquid biopsy blood test showed in a study that it can help physicians select prostate cancer patients who are likely to benefit from a Pfizer prostate-specific membrane antigen (PSMA)-targeted therapy candidate known as BIND-014 before the start of treatment. [Source: © Alex Tihonov/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1907-324x160.jpeg "Canadian Consortium Backs Liquid Biopsy Solution to Increase Cancer Testing Access During the Pandemic")
